Daily News Day 3 Annual Meeting coverage continues with Plenary recaps and abstract commentaries, a preview of today’s Keynotes, Journals articles featuring Annual Meeting content and more!
NRG Oncology/RTOG 0815
NRG/RTOG 0815 demonstrates that short-term ADT improves metastasis-free survival in men receiving dose-escalated radiation therapy with intermediate-risk prostate cancer.
Hypofractionation is the preferred treatment type of radiation therapy for intact prostate cancer: Is it now also for post-prostatectomy RT based on NRG GU003?
Phase II study investigates the potential of ADC as a predictive MRI biomarker for radiation treatment efficacy for nasopharyngeal concurrent chemo/RT.
RADIOPARP Phase I Trial
RADIOPARP phase I trial evaluating olaparib with radiation therapy for triple negative breast cancer demonstrates acceptable toxicity profile with zero grade 3+ adverse events.
Cancer Support Center
One of the 2021 ASTRO Survivor Circle Grant reciepients, the CSC serves anyone seeking oncology care and focuses on a health equity initiative providing services to communities of color with high cancer morbidity rates.
LivingWell Cancer Resource Center
One of the 2021 ASTRO Survivor Circle Grant recipients, LWCRC is a free oncology support center that provides services to empower people facing cancer with knowledge, strengthened by action and sustained by the supportive LivingWell community.